Reduced Cardiovascular Disease Incidence With a National Lifestyle Change Program

Published:December 06, 2016DOI:


      Lifestyle change programs implemented within healthcare systems could reach many Americans, but their impact on cardiovascular disease (CVD) remains unclear. The MOVE! program is the largest lifestyle change program implemented in a healthcare setting in the U.S. This study aimed to determine whether MOVE! participation was associated with reduced CVD incidence.


      This retrospective cohort study, analyzed in 2013–2015, used national Veterans Health Administration databases to identify MOVE! participants and eligible non-participants for comparison (2005–2012). Patients eligible for MOVE!—obese or overweight with a weight-related health condition, and no baseline CVD—were examined (N=1,463,003). Of these, 169,248 (12%) were MOVE! participants. Patients were 92% male, 76% white, with mean age 52 years and BMI of 32. The main outcome was incidence of CVD (ICD-9 and procedure codes for coronary artery disease, cerebrovascular disease, peripheral vascular disease, and heart failure).


      Adjusting for age, race, sex, BMI, statin use, and baseline comorbidities, over a mean 4.9 years of follow-up, MOVE! participation was associated with lower incidence of total CVD (hazard ratio [HR]=0.83, 95% CI=0.80, 0.86); coronary artery disease (HR=0.81, 95% CI=0.77, 0.86); cerebrovascular disease (HR=0.87, 95% CI=0.82, 0.92); peripheral vascular disease (HR=0.89, 95% CI=0.83, 0.94); and heart failure (HR=0.78, 95% CI=0.74, 0.83). The association between MOVE! participation and CVD incidence remained significant when examined across categories of race/ethnicity, BMI, diabetes, hypertension, smoking status, and statin use.


      Although participation was limited, MOVE! was associated with reduced CVD incidence in a nationwide healthcare setting.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Roger V.L.
        • Go A.S.
        • Lloyd-Jones D.M.
        • et al.
        Heart disease and stroke statistics—2011 update: a report from the American Heart Association.
        Circulation. 2011; 123: e18-e209
        • Heidenreich P.A.
        • Trogdon J.G.
        • Khavjou O.A.
        • et al.
        Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
        Circulation. 2011; 123: 933-944
        • Stampfer M.J.
        • Hu F.B.
        • Manson J.E.
        • Rimm E.B.
        • Willett W.C.
        Primary prevention of coronary heart disease in women through diet and lifestyle.
        N Engl J Med. 2000; 343: 16-22
        • Schieb L.J.
        • Greer S.A.
        • Ritchey M.D.
        • George M.G.
        • Casper M.L.
        Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease—United States, 2001–2010.
        MMWR Morb Mortal Wkly Rep. 2013; 62: 721-727
        • Diabetes Prevention Program Research Group
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        • Pan X.-R.
        • Li G.-W.
        • Hu Y.-H.
        • et al.
        Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study.
        Diabetes Care. 1997; 20: 537-544
        • Lindström J.
        • Louheranta A.
        • Mannelin M.
        • et al.
        The Finnish Diabetes Prevention Study (DPS).
        Diabetes Care. 2003; 26: 3230-3236
        • The Look AHEAD Research Group
        Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD Trial.
        Arch Intern Med. 2010; 170: 1566-1575
        • Ornish D.
        • Scherwitz L.W.
        • Billings J.H.
        • et al.
        Intensive lifestyle changes for reversal of coronary heart disease.
        JAMA. 1998; 280: 2001-2007
        • Schellenberg E.S.
        • Dryden D.M.
        • Vandermeer B.
        • Ha C.
        • Korownyk C.
        Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis.
        Ann Intern Med. 2013; 159: 543-551
        • de Waure C.
        • Lauret G.J.
        • Ricciardi W.
        • et al.
        Lifestyle interventions in patients with coronary heart disease: a systematic review.
        Am J Prev Med. 2013; 45: 207-216
        • Orchard T.J.
        • Temprosa M.
        • Barrett-Connor E.
        • et al.
        Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.
        Diabet Med. 2013; 30: 46-55
        • Look AHEAD Research Group
        Cardiovascular effects of intensive lifestyle intervention in Type 2 diabetes.
        N Engl J Med. 2013; 369: 145-154
      1. National Center for Veterans Analysis and Statistics. Trends in the utilization of VA programs and services. Published 2012. Accessed November 29, 2013.

        • Nelson K.M.
        The burden of obesity among a national probability sample of veterans.
        J Gen Intern Med. 2006; 21: 915-919
        • Johnson M.L.
        • Pietz K.
        • Battleman D.S.
        • Beyth R.J.
        Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.
        Am J Manag Care. 2004; 10: 926-932
        • NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (U.S.)
        Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report.
        National Heart, Lung, and Blood Institute, Bethesda, MD1998
        • Littman A.J.
        • Boyko E.J.
        • McDonell M.B.
        • Fihn S.D.
        Evaluation of a weight management program for veterans.
        Prev Chronic Dis. 2012; : 9
        • Jackson S.L.
        • Long Q.
        • Rhee M.K.
        • et al.
        Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study.
        Lancet Diabetes Endocrinol. 2015; 3: 173-180
      2. VA Health Services Research and Development Service. VA informatics and computing infrastructure. Published 2012. Accessed February 3, 2013.

        • Kinsinger L.S.
        • Jones K.R.
        • Kahwati L.
        • et al.
        Design and dissemination of the MOVE! Weight-Management Program for Veterans.
        Prev Chronic Dis. 2009; 6: A98
        • Kahwati L.C.
        • Lewis M.A.
        • Kane H.
        • et al.
        Best practices in the Veterans Health Administration׳s MOVE! Weight Management Program.
        Am J Prev Med. 2011; 41: 457-464
        • Flicker L.
        • McCaul K.A.
        • Hankey G.J.
        • et al.
        Body mass index and survival in men and women aged 70 to 75.
        J Am Geriatr Soc. 2010; 58: 234-241
        • Zamboni M.
        • Mazzali G.
        • Zoico E.
        • et al.
        Health consequences of obesity in the elderly: a review of four unresolved questions.
        Int J Obes (Lond). 2005; 29: 1011-1029
        • Noël P.H.
        • Copeland L.A.
        • Perrin R.A.
        • et al.
        VHA Corporate Data Warehouse height and weight data: opportunities and challenges for health services research.
        J Rehabil Res Dev. 2010; 47: 739-750
        • McGinnis K.A.
        • Brandt C.A.
        • Skanderson M.
        • et al.
        Validating smoking data from the Veteran׳s Affairs Health Factors dataset, an electronic data source.
        Nicotine Tob Res. 2011; 13: 1233-1239
        • Quan H.
        • Sundararajan V.
        • Halfon P.
        • et al.
        Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.
        Med Care. 2005; 43: 1130-1139
        • Young B.A.
        • Maynard C.
        • Boyko E.J.
        Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans.
        Diabetes Care. 2003; 26: 2392-2399
        • Lee E.W.
        • Wei L.J.
        • Amato D.
        Cox-Type Regression Analysis for Large Numbers of Small Groups of Correlated Failure Time Observations.
        Kluwer Academic, Netherlands1992
        • D’Agostino R.B.
        Propensity scores in cardiovascular research.
        Circulation. 2007; 115: 2340-2343
        • Kahwati L.C.
        • Lance T.X.
        • Jones K.R.
        • Kinsinger L.S.
        RE-AIM evaluation of the Veterans Health Administration's MOVE! Weight Management Program.
        Transl Behav Med. 2011; 1: 551-560
        • Ebrahim S.
        • Taylor F.
        • Ward K.
        • Beswick A.
        • Burke M.
        • Davey Smith G.
        Multiple risk factor interventions for primary prevention of coronary heart disease.
        Cochrane Database Syst Rev. 2011; 1: CD001561
        • Goodpaster B.H.
        • Delany J.P.
        • Otto A.D.
        • et al.
        Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial.
        JAMA. 2010; 304: 1795-1802
        • Gerstein H.C.
        Do lifestyle changes reduce serious outcomes in diabetes?.
        N Engl J Med. 2013; 369: 189-190
        • Li G.
        • Zhang P.
        • Wang J.
        • et al.
        Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
        Lancet Diabetes Endocrinol. 2014; 2: 474-480
        • Després J.-P.
        Obesity and cardiovascular disease: weight loss is not the only target.
        Can J Cardiol. 2015; 31: 216-222
        • Littman A.J.
        • Damschroder L.J.
        • Verchinina L.
        • et al.
        National evaluation of obesity screening and treatment among veterans with and without mental health disorders.
        Gen Hosp Psychiatry. 2015; 37: 7-13
        • Borowsky S.J.
        • Cowper D.C.
        Dual use of VA and non-VA primary care.
        J Gen Intern Med. 1999; 14: 274-280
        • Liu C.-F.
        • Manning W.G.
        • Burgess J.F.J.
        • et al.
        Reliance on Veterans Affairs outpatient care by Medicare-eligible veterans.
        Medical Care. 2011; 49: 911-917
        • Liu C.F.
        • Chapko M.
        • Bryson C.L.
        • et al.
        Use of outpatient care in Veterans Health Administration and Medicare among veterans receiving primary care in community-based and hospital outpatient clinics.
        Health Serv Res. 2010; 45: 1268-1286